nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ALB—ulcerative colitis	0.18	0.512	CbGaD
Tacrolimus—ABCB1—ulcerative colitis	0.172	0.488	CbGaD
Tacrolimus—CYP3A4—Budesonide—ulcerative colitis	0.0258	0.0789	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.024	0.0733	CbGbCtD
Tacrolimus—CYP3A7—Hydrocortisone—ulcerative colitis	0.024	0.0733	CbGbCtD
Tacrolimus—CYP3A5—Sulfasalazine—ulcerative colitis	0.0224	0.0685	CbGbCtD
Tacrolimus—ALB—Prednisone—ulcerative colitis	0.0223	0.0682	CbGbCtD
Tacrolimus—ABCB1—Methylprednisolone—ulcerative colitis	0.0192	0.0588	CbGbCtD
Tacrolimus—CYP3A5—Hydrocortisone—ulcerative colitis	0.018	0.055	CbGbCtD
Tacrolimus—CYP3A7—Dexamethasone—ulcerative colitis	0.0149	0.0456	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.0149	0.0456	CbGbCtD
Tacrolimus—ABCB1—Betamethasone—ulcerative colitis	0.0125	0.0383	CbGbCtD
Tacrolimus—ABCB1—Prednisolone—ulcerative colitis	0.0123	0.0378	CbGbCtD
Tacrolimus—ABCB1—Hydrocortisone—ulcerative colitis	0.0117	0.0358	CbGbCtD
Tacrolimus—ABCB1—Prednisone—ulcerative colitis	0.0117	0.0357	CbGbCtD
Tacrolimus—CYP3A4—Methylprednisolone—ulcerative colitis	0.0115	0.0353	CbGbCtD
Tacrolimus—CYP3A4—Nicotine—ulcerative colitis	0.0112	0.0344	CbGbCtD
Tacrolimus—CYP3A5—Dexamethasone—ulcerative colitis	0.0112	0.0342	CbGbCtD
Tacrolimus—CYP3A4—Cholecalciferol—ulcerative colitis	0.0101	0.0308	CbGbCtD
Tacrolimus—CYP3A4—Triamcinolone—ulcerative colitis	0.00874	0.0267	CbGbCtD
Tacrolimus—CYP3A4—Betamethasone—ulcerative colitis	0.00749	0.0229	CbGbCtD
Tacrolimus—CYP3A4—Prednisolone—ulcerative colitis	0.0074	0.0226	CbGbCtD
Tacrolimus—ABCB1—Dexamethasone—ulcerative colitis	0.00728	0.0223	CbGbCtD
Tacrolimus—ORM1—bile—ulcerative colitis	0.00725	0.229	CbGeAlD
Tacrolimus—CYP3A4—Hydrocortisone—ulcerative colitis	0.00701	0.0214	CbGbCtD
Tacrolimus—CYP3A4—Prednisone—ulcerative colitis	0.00698	0.0214	CbGbCtD
Tacrolimus—CYP3A4—Dexamethasone—ulcerative colitis	0.00436	0.0133	CbGbCtD
Tacrolimus—PPP3CA—smooth muscle tissue—ulcerative colitis	0.00193	0.061	CbGeAlD
Tacrolimus—ABCA5—liver—ulcerative colitis	0.00168	0.0532	CbGeAlD
Tacrolimus—PPP3CA—lymphoid tissue—ulcerative colitis	0.00154	0.0488	CbGeAlD
Tacrolimus—PPP3CA—digestive system—ulcerative colitis	0.00152	0.0482	CbGeAlD
Tacrolimus—MTOR—epithelium—ulcerative colitis	0.00148	0.0468	CbGeAlD
Tacrolimus—MTOR—smooth muscle tissue—ulcerative colitis	0.00142	0.0451	CbGeAlD
Tacrolimus—FKBP1A—epithelium—ulcerative colitis	0.00133	0.0421	CbGeAlD
Tacrolimus—FKBP1A—smooth muscle tissue—ulcerative colitis	0.00128	0.0406	CbGeAlD
Tacrolimus—MTOR—lymphoid tissue—ulcerative colitis	0.00114	0.036	CbGeAlD
Tacrolimus—PPP3CA—liver—ulcerative colitis	0.00113	0.0359	CbGeAlD
Tacrolimus—MTOR—digestive system—ulcerative colitis	0.00112	0.0356	CbGeAlD
Tacrolimus—FKBP1A—lymphoid tissue—ulcerative colitis	0.00102	0.0324	CbGeAlD
Tacrolimus—FKBP1A—digestive system—ulcerative colitis	0.00101	0.032	CbGeAlD
Tacrolimus—CYP3A7—liver—ulcerative colitis	0.000932	0.0295	CbGeAlD
Tacrolimus—MTOR—liver—ulcerative colitis	0.000838	0.0265	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—liver—ulcerative colitis	0.000793	0.0251	CbGeAlD
Tacrolimus—FKBP1A—liver—ulcerative colitis	0.000754	0.0239	CbGeAlD
Tacrolimus—ORM1—liver—ulcerative colitis	0.00059	0.0187	CbGeAlD
Tacrolimus—ALB—liver—ulcerative colitis	0.000517	0.0164	CbGeAlD
Tacrolimus—CYP3A5—digestive system—ulcerative colitis	0.00044	0.0139	CbGeAlD
Tacrolimus—Temsirolimus—ABCB1—ulcerative colitis	0.000409	0.532	CrCbGaD
Tacrolimus—Sirolimus—ABCB1—ulcerative colitis	0.00036	0.468	CrCbGaD
Tacrolimus—CYP3A4—digestive system—ulcerative colitis	0.000331	0.0105	CbGeAlD
Tacrolimus—CYP3A5—liver—ulcerative colitis	0.000328	0.0104	CbGeAlD
Tacrolimus—ABCB1—epithelium—ulcerative colitis	0.000308	0.00974	CbGeAlD
Tacrolimus—CYP3A4—liver—ulcerative colitis	0.000246	0.0078	CbGeAlD
Tacrolimus—ABCB1—lymphoid tissue—ulcerative colitis	0.000237	0.0075	CbGeAlD
Tacrolimus—ABCB1—digestive system—ulcerative colitis	0.000234	0.00741	CbGeAlD
Tacrolimus—ABCB1—liver—ulcerative colitis	0.000174	0.00552	CbGeAlD
Tacrolimus—Nervous system disorder—Hydrocortisone—ulcerative colitis	4.67e-05	0.000227	CcSEcCtD
Tacrolimus—Myalgia—Methylprednisolone—ulcerative colitis	4.67e-05	0.000226	CcSEcCtD
Tacrolimus—Arthralgia—Methylprednisolone—ulcerative colitis	4.67e-05	0.000226	CcSEcCtD
Tacrolimus—Eye disorder—Prednisone—ulcerative colitis	4.66e-05	0.000226	CcSEcCtD
Tacrolimus—Anxiety—Methylprednisolone—ulcerative colitis	4.65e-05	0.000226	CcSEcCtD
Tacrolimus—Tachycardia—Hydrocortisone—ulcerative colitis	4.65e-05	0.000225	CcSEcCtD
Tacrolimus—Rash—Azathioprine—ulcerative colitis	4.64e-05	0.000225	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	4.64e-05	0.000225	CcSEcCtD
Tacrolimus—Dermatitis—Azathioprine—ulcerative colitis	4.63e-05	0.000225	CcSEcCtD
Tacrolimus—Flushing—Prednisone—ulcerative colitis	4.63e-05	0.000225	CcSEcCtD
Tacrolimus—Skin disorder—Hydrocortisone—ulcerative colitis	4.63e-05	0.000224	CcSEcCtD
Tacrolimus—Ill-defined disorder—Betamethasone—ulcerative colitis	4.63e-05	0.000224	CcSEcCtD
Tacrolimus—Ill-defined disorder—Dexamethasone—ulcerative colitis	4.63e-05	0.000224	CcSEcCtD
Tacrolimus—Discomfort—Triamcinolone—ulcerative colitis	4.62e-05	0.000224	CcSEcCtD
Tacrolimus—Discomfort—Methylprednisolone—ulcerative colitis	4.61e-05	0.000224	CcSEcCtD
Tacrolimus—Headache—Azathioprine—ulcerative colitis	4.61e-05	0.000223	CcSEcCtD
Tacrolimus—Hyperhidrosis—Hydrocortisone—ulcerative colitis	4.61e-05	0.000223	CcSEcCtD
Tacrolimus—Diarrhoea—Mesalazine—ulcerative colitis	4.58e-05	0.000222	CcSEcCtD
Tacrolimus—Dry mouth—Triamcinolone—ulcerative colitis	4.58e-05	0.000222	CcSEcCtD
Tacrolimus—Anorexia—Hydrocortisone—ulcerative colitis	4.54e-05	0.00022	CcSEcCtD
Tacrolimus—Angiopathy—Prednisone—ulcerative colitis	4.53e-05	0.00022	CcSEcCtD
Tacrolimus—Confusional state—Methylprednisolone—ulcerative colitis	4.51e-05	0.000219	CcSEcCtD
Tacrolimus—Immune system disorder—Prednisone—ulcerative colitis	4.51e-05	0.000219	CcSEcCtD
Tacrolimus—Malaise—Dexamethasone—ulcerative colitis	4.5e-05	0.000218	CcSEcCtD
Tacrolimus—Malaise—Betamethasone—ulcerative colitis	4.5e-05	0.000218	CcSEcCtD
Tacrolimus—Oedema—Triamcinolone—ulcerative colitis	4.49e-05	0.000218	CcSEcCtD
Tacrolimus—Anaphylactic shock—Triamcinolone—ulcerative colitis	4.49e-05	0.000218	CcSEcCtD
Tacrolimus—Vertigo—Betamethasone—ulcerative colitis	4.48e-05	0.000217	CcSEcCtD
Tacrolimus—Vertigo—Dexamethasone—ulcerative colitis	4.48e-05	0.000217	CcSEcCtD
Tacrolimus—Anaphylactic shock—Methylprednisolone—ulcerative colitis	4.48e-05	0.000217	CcSEcCtD
Tacrolimus—Syncope—Dexamethasone—ulcerative colitis	4.47e-05	0.000217	CcSEcCtD
Tacrolimus—Syncope—Betamethasone—ulcerative colitis	4.47e-05	0.000217	CcSEcCtD
Tacrolimus—Arrhythmia—Prednisone—ulcerative colitis	4.46e-05	0.000216	CcSEcCtD
Tacrolimus—Infection—Triamcinolone—ulcerative colitis	4.46e-05	0.000216	CcSEcCtD
Tacrolimus—Hypotension—Hydrocortisone—ulcerative colitis	4.45e-05	0.000216	CcSEcCtD
Tacrolimus—Infection—Methylprednisolone—ulcerative colitis	4.45e-05	0.000216	CcSEcCtD
Tacrolimus—Dizziness—Mesalazine—ulcerative colitis	4.43e-05	0.000215	CcSEcCtD
Tacrolimus—Shock—Triamcinolone—ulcerative colitis	4.41e-05	0.000214	CcSEcCtD
Tacrolimus—Insomnia—Prednisolone—ulcerative colitis	4.41e-05	0.000214	CcSEcCtD
Tacrolimus—Alopecia—Prednisone—ulcerative colitis	4.41e-05	0.000214	CcSEcCtD
Tacrolimus—Shock—Methylprednisolone—ulcerative colitis	4.4e-05	0.000214	CcSEcCtD
Tacrolimus—Nervous system disorder—Methylprednisolone—ulcerative colitis	4.39e-05	0.000213	CcSEcCtD
Tacrolimus—Loss of consciousness—Betamethasone—ulcerative colitis	4.38e-05	0.000213	CcSEcCtD
Tacrolimus—Loss of consciousness—Dexamethasone—ulcerative colitis	4.38e-05	0.000213	CcSEcCtD
Tacrolimus—Paraesthesia—Prednisolone—ulcerative colitis	4.38e-05	0.000212	CcSEcCtD
Tacrolimus—Tachycardia—Triamcinolone—ulcerative colitis	4.38e-05	0.000212	CcSEcCtD
Tacrolimus—Mental disorder—Prednisone—ulcerative colitis	4.37e-05	0.000212	CcSEcCtD
Tacrolimus—Nausea—Azathioprine—ulcerative colitis	4.37e-05	0.000212	CcSEcCtD
Tacrolimus—Tachycardia—Methylprednisolone—ulcerative colitis	4.37e-05	0.000212	CcSEcCtD
Tacrolimus—Skin disorder—Methylprednisolone—ulcerative colitis	4.35e-05	0.000211	CcSEcCtD
Tacrolimus—Erythema—Prednisone—ulcerative colitis	4.34e-05	0.000211	CcSEcCtD
Tacrolimus—Malnutrition—Prednisone—ulcerative colitis	4.34e-05	0.000211	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	4.34e-05	0.00021	CcSEcCtD
Tacrolimus—Hyperhidrosis—Triamcinolone—ulcerative colitis	4.34e-05	0.00021	CcSEcCtD
Tacrolimus—Hyperhidrosis—Methylprednisolone—ulcerative colitis	4.33e-05	0.00021	CcSEcCtD
Tacrolimus—Convulsion—Dexamethasone—ulcerative colitis	4.32e-05	0.00021	CcSEcCtD
Tacrolimus—Convulsion—Betamethasone—ulcerative colitis	4.32e-05	0.00021	CcSEcCtD
Tacrolimus—Insomnia—Hydrocortisone—ulcerative colitis	4.31e-05	0.000209	CcSEcCtD
Tacrolimus—Hypertension—Betamethasone—ulcerative colitis	4.31e-05	0.000209	CcSEcCtD
Tacrolimus—Hypertension—Dexamethasone—ulcerative colitis	4.31e-05	0.000209	CcSEcCtD
Tacrolimus—Paraesthesia—Hydrocortisone—ulcerative colitis	4.28e-05	0.000207	CcSEcCtD
Tacrolimus—Vomiting—Mesalazine—ulcerative colitis	4.26e-05	0.000207	CcSEcCtD
Tacrolimus—Myalgia—Dexamethasone—ulcerative colitis	4.25e-05	0.000206	CcSEcCtD
Tacrolimus—Myalgia—Betamethasone—ulcerative colitis	4.25e-05	0.000206	CcSEcCtD
Tacrolimus—Anxiety—Betamethasone—ulcerative colitis	4.23e-05	0.000205	CcSEcCtD
Tacrolimus—Anxiety—Dexamethasone—ulcerative colitis	4.23e-05	0.000205	CcSEcCtD
Tacrolimus—Rash—Mesalazine—ulcerative colitis	4.22e-05	0.000205	CcSEcCtD
Tacrolimus—Dermatitis—Mesalazine—ulcerative colitis	4.22e-05	0.000205	CcSEcCtD
Tacrolimus—Headache—Mesalazine—ulcerative colitis	4.2e-05	0.000204	CcSEcCtD
Tacrolimus—Discomfort—Dexamethasone—ulcerative colitis	4.19e-05	0.000203	CcSEcCtD
Tacrolimus—Discomfort—Betamethasone—ulcerative colitis	4.19e-05	0.000203	CcSEcCtD
Tacrolimus—Dyspepsia—Hydrocortisone—ulcerative colitis	4.19e-05	0.000203	CcSEcCtD
Tacrolimus—Hypotension—Methylprednisolone—ulcerative colitis	4.18e-05	0.000203	CcSEcCtD
Tacrolimus—Pain—Prednisolone—ulcerative colitis	4.17e-05	0.000202	CcSEcCtD
Tacrolimus—Decreased appetite—Hydrocortisone—ulcerative colitis	4.14e-05	0.000201	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	4.11e-05	0.000199	CcSEcCtD
Tacrolimus—Fatigue—Hydrocortisone—ulcerative colitis	4.11e-05	0.000199	CcSEcCtD
Tacrolimus—Vision blurred—Prednisone—ulcerative colitis	4.09e-05	0.000199	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	4.09e-05	0.000198	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	4.08e-05	0.000198	CcSEcCtD
Tacrolimus—Pain—Hydrocortisone—ulcerative colitis	4.07e-05	0.000198	CcSEcCtD
Tacrolimus—Anaphylactic shock—Dexamethasone—ulcerative colitis	4.07e-05	0.000197	CcSEcCtD
Tacrolimus—Oedema—Betamethasone—ulcerative colitis	4.07e-05	0.000197	CcSEcCtD
Tacrolimus—Anaphylactic shock—Betamethasone—ulcerative colitis	4.07e-05	0.000197	CcSEcCtD
Tacrolimus—Oedema—Dexamethasone—ulcerative colitis	4.07e-05	0.000197	CcSEcCtD
Tacrolimus—Insomnia—Triamcinolone—ulcerative colitis	4.06e-05	0.000197	CcSEcCtD
Tacrolimus—Insomnia—Methylprednisolone—ulcerative colitis	4.05e-05	0.000196	CcSEcCtD
Tacrolimus—Infection—Betamethasone—ulcerative colitis	4.04e-05	0.000196	CcSEcCtD
Tacrolimus—Infection—Dexamethasone—ulcerative colitis	4.04e-05	0.000196	CcSEcCtD
Tacrolimus—Ill-defined disorder—Prednisone—ulcerative colitis	4.03e-05	0.000195	CcSEcCtD
Tacrolimus—Paraesthesia—Triamcinolone—ulcerative colitis	4.03e-05	0.000195	CcSEcCtD
Tacrolimus—Feeling abnormal—Prednisolone—ulcerative colitis	4.02e-05	0.000195	CcSEcCtD
Tacrolimus—Paraesthesia—Methylprednisolone—ulcerative colitis	4.02e-05	0.000195	CcSEcCtD
Tacrolimus—Anaemia—Prednisone—ulcerative colitis	4.01e-05	0.000195	CcSEcCtD
Tacrolimus—Shock—Betamethasone—ulcerative colitis	4e-05	0.000194	CcSEcCtD
Tacrolimus—Shock—Dexamethasone—ulcerative colitis	4e-05	0.000194	CcSEcCtD
Tacrolimus—Dyspnoea—Triamcinolone—ulcerative colitis	4e-05	0.000194	CcSEcCtD
Tacrolimus—Nervous system disorder—Dexamethasone—ulcerative colitis	3.99e-05	0.000194	CcSEcCtD
Tacrolimus—Nervous system disorder—Betamethasone—ulcerative colitis	3.99e-05	0.000194	CcSEcCtD
Tacrolimus—Agitation—Prednisone—ulcerative colitis	3.99e-05	0.000194	CcSEcCtD
Tacrolimus—Thrombocytopenia—Dexamethasone—ulcerative colitis	3.98e-05	0.000193	CcSEcCtD
Tacrolimus—Thrombocytopenia—Betamethasone—ulcerative colitis	3.98e-05	0.000193	CcSEcCtD
Tacrolimus—Nausea—Mesalazine—ulcerative colitis	3.98e-05	0.000193	CcSEcCtD
Tacrolimus—Tachycardia—Dexamethasone—ulcerative colitis	3.97e-05	0.000193	CcSEcCtD
Tacrolimus—Tachycardia—Betamethasone—ulcerative colitis	3.97e-05	0.000193	CcSEcCtD
Tacrolimus—Dyspepsia—Triamcinolone—ulcerative colitis	3.95e-05	0.000192	CcSEcCtD
Tacrolimus—Dyspepsia—Methylprednisolone—ulcerative colitis	3.94e-05	0.000191	CcSEcCtD
Tacrolimus—Hyperhidrosis—Betamethasone—ulcerative colitis	3.93e-05	0.000191	CcSEcCtD
Tacrolimus—Hyperhidrosis—Dexamethasone—ulcerative colitis	3.93e-05	0.000191	CcSEcCtD
Tacrolimus—Feeling abnormal—Hydrocortisone—ulcerative colitis	3.93e-05	0.00019	CcSEcCtD
Tacrolimus—Malaise—Prednisone—ulcerative colitis	3.92e-05	0.00019	CcSEcCtD
Tacrolimus—Vertigo—Prednisone—ulcerative colitis	3.9e-05	0.000189	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	3.9e-05	0.000189	CcSEcCtD
Tacrolimus—Syncope—Prednisone—ulcerative colitis	3.89e-05	0.000189	CcSEcCtD
Tacrolimus—Anorexia—Betamethasone—ulcerative colitis	3.88e-05	0.000188	CcSEcCtD
Tacrolimus—Anorexia—Dexamethasone—ulcerative colitis	3.88e-05	0.000188	CcSEcCtD
Tacrolimus—Urticaria—Prednisolone—ulcerative colitis	3.87e-05	0.000188	CcSEcCtD
Tacrolimus—Fatigue—Triamcinolone—ulcerative colitis	3.87e-05	0.000188	CcSEcCtD
Tacrolimus—Fatigue—Methylprednisolone—ulcerative colitis	3.86e-05	0.000187	CcSEcCtD
Tacrolimus—Pain—Triamcinolone—ulcerative colitis	3.84e-05	0.000186	CcSEcCtD
Tacrolimus—Loss of consciousness—Prednisone—ulcerative colitis	3.82e-05	0.000185	CcSEcCtD
Tacrolimus—Hypotension—Betamethasone—ulcerative colitis	3.8e-05	0.000184	CcSEcCtD
Tacrolimus—Hypotension—Dexamethasone—ulcerative colitis	3.8e-05	0.000184	CcSEcCtD
Tacrolimus—Urticaria—Hydrocortisone—ulcerative colitis	3.78e-05	0.000184	CcSEcCtD
Tacrolimus—Body temperature increased—Hydrocortisone—ulcerative colitis	3.77e-05	0.000183	CcSEcCtD
Tacrolimus—Abdominal pain—Hydrocortisone—ulcerative colitis	3.77e-05	0.000183	CcSEcCtD
Tacrolimus—Convulsion—Prednisone—ulcerative colitis	3.76e-05	0.000182	CcSEcCtD
Tacrolimus—Hypertension—Prednisone—ulcerative colitis	3.75e-05	0.000182	CcSEcCtD
Tacrolimus—PPP3CA—Innate Immune System—NFKB1—ulcerative colitis	3.75e-05	0.000454	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—IL6—ulcerative colitis	3.73e-05	0.000451	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	3.71e-05	0.00018	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	3.71e-05	0.00018	CcSEcCtD
Tacrolimus—MTOR—Signaling by Insulin receptor—IL6—ulcerative colitis	3.7e-05	0.000448	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	3.7e-05	0.000448	CbGpPWpGaD
Tacrolimus—Arthralgia—Prednisone—ulcerative colitis	3.7e-05	0.000179	CcSEcCtD
Tacrolimus—Myalgia—Prednisone—ulcerative colitis	3.7e-05	0.000179	CcSEcCtD
Tacrolimus—Feeling abnormal—Triamcinolone—ulcerative colitis	3.7e-05	0.000179	CcSEcCtD
Tacrolimus—MTOR—Signaling by PDGF—STAT3—ulcerative colitis	3.69e-05	0.000447	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.69e-05	0.000179	CcSEcCtD
Tacrolimus—ABCB1—Allograft Rejection—IL2—ulcerative colitis	3.69e-05	0.000446	CbGpPWpGaD
Tacrolimus—Anxiety—Prednisone—ulcerative colitis	3.68e-05	0.000179	CcSEcCtD
Tacrolimus—Insomnia—Dexamethasone—ulcerative colitis	3.68e-05	0.000179	CcSEcCtD
Tacrolimus—Insomnia—Betamethasone—ulcerative colitis	3.68e-05	0.000179	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.67e-05	0.000178	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.66e-05	0.000178	CcSEcCtD
Tacrolimus—Paraesthesia—Dexamethasone—ulcerative colitis	3.65e-05	0.000177	CcSEcCtD
Tacrolimus—Paraesthesia—Betamethasone—ulcerative colitis	3.65e-05	0.000177	CcSEcCtD
Tacrolimus—Discomfort—Prednisone—ulcerative colitis	3.65e-05	0.000177	CcSEcCtD
Tacrolimus—MTOR—Adaptive Immune System—VCAM1—ulcerative colitis	3.64e-05	0.000441	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ITGAL—ulcerative colitis	3.63e-05	0.00044	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-DQA1—ulcerative colitis	3.63e-05	0.000439	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—RELA—ulcerative colitis	3.62e-05	0.000438	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	3.61e-05	0.000437	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—DLD—ulcerative colitis	3.61e-05	0.000437	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAML2—ulcerative colitis	3.6e-05	0.000435	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—TLR4—ulcerative colitis	3.59e-05	0.000435	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Prednisolone—ulcerative colitis	3.59e-05	0.000174	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—HLA-DRB1—ulcerative colitis	3.59e-05	0.000435	CbGpPWpGaD
Tacrolimus—Dyspepsia—Betamethasone—ulcerative colitis	3.58e-05	0.000174	CcSEcCtD
Tacrolimus—Dyspepsia—Dexamethasone—ulcerative colitis	3.58e-05	0.000174	CcSEcCtD
Tacrolimus—Urticaria—Triamcinolone—ulcerative colitis	3.56e-05	0.000173	CcSEcCtD
Tacrolimus—Urticaria—Methylprednisolone—ulcerative colitis	3.56e-05	0.000172	CcSEcCtD
Tacrolimus—Body temperature increased—Triamcinolone—ulcerative colitis	3.55e-05	0.000172	CcSEcCtD
Tacrolimus—Oedema—Prednisone—ulcerative colitis	3.54e-05	0.000172	CcSEcCtD
Tacrolimus—Anaphylactic shock—Prednisone—ulcerative colitis	3.54e-05	0.000172	CcSEcCtD
Tacrolimus—Abdominal pain—Methylprednisolone—ulcerative colitis	3.54e-05	0.000172	CcSEcCtD
Tacrolimus—Decreased appetite—Betamethasone—ulcerative colitis	3.54e-05	0.000172	CcSEcCtD
Tacrolimus—Decreased appetite—Dexamethasone—ulcerative colitis	3.54e-05	0.000172	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—TNF—ulcerative colitis	3.54e-05	0.000428	CbGpPWpGaD
Tacrolimus—Infection—Prednisone—ulcerative colitis	3.52e-05	0.000171	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—SEL1L—ulcerative colitis	3.52e-05	0.000426	CbGpPWpGaD
Tacrolimus—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.51e-05	0.00017	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.51e-05	0.00017	CcSEcCtD
Tacrolimus—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.51e-05	0.00017	CcSEcCtD
Tacrolimus—Fatigue—Betamethasone—ulcerative colitis	3.51e-05	0.00017	CcSEcCtD
Tacrolimus—Fatigue—Dexamethasone—ulcerative colitis	3.51e-05	0.00017	CcSEcCtD
Tacrolimus—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	3.51e-05	0.000425	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—JAK2—ulcerative colitis	3.51e-05	0.000425	CbGpPWpGaD
Tacrolimus—Shock—Prednisone—ulcerative colitis	3.49e-05	0.000169	CcSEcCtD
Tacrolimus—Pain—Dexamethasone—ulcerative colitis	3.48e-05	0.000169	CcSEcCtD
Tacrolimus—Pain—Betamethasone—ulcerative colitis	3.48e-05	0.000169	CcSEcCtD
Tacrolimus—Nervous system disorder—Prednisone—ulcerative colitis	3.48e-05	0.000169	CcSEcCtD
Tacrolimus—ALB—Hemostasis—GNA12—ulcerative colitis	3.47e-05	0.00042	CbGpPWpGaD
Tacrolimus—Tachycardia—Prednisone—ulcerative colitis	3.46e-05	0.000168	CcSEcCtD
Tacrolimus—MTOR—Immune System—IRF5—ulcerative colitis	3.45e-05	0.000418	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—ICAM1—ulcerative colitis	3.45e-05	0.000417	CbGpPWpGaD
Tacrolimus—Skin disorder—Prednisone—ulcerative colitis	3.44e-05	0.000167	CcSEcCtD
Tacrolimus—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	3.43e-05	0.000415	CbGpPWpGaD
Tacrolimus—Hyperhidrosis—Prednisone—ulcerative colitis	3.43e-05	0.000166	CcSEcCtD
Tacrolimus—Asthenia—Hydrocortisone—ulcerative colitis	3.42e-05	0.000166	CcSEcCtD
Tacrolimus—MTOR—Cellular responses to stress—CXCL8—ulcerative colitis	3.41e-05	0.000413	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—ITGAL—ulcerative colitis	3.4e-05	0.000412	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—RELA—ulcerative colitis	3.4e-05	0.000411	CbGpPWpGaD
Tacrolimus—Anorexia—Prednisone—ulcerative colitis	3.38e-05	0.000164	CcSEcCtD
Tacrolimus—Pruritus—Hydrocortisone—ulcerative colitis	3.37e-05	0.000163	CcSEcCtD
Tacrolimus—Feeling abnormal—Dexamethasone—ulcerative colitis	3.35e-05	0.000163	CcSEcCtD
Tacrolimus—Feeling abnormal—Betamethasone—ulcerative colitis	3.35e-05	0.000163	CcSEcCtD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—ulcerative colitis	3.35e-05	0.000405	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PTGER4—ulcerative colitis	3.34e-05	0.000404	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.33e-05	0.000161	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.33e-05	0.000161	CcSEcCtD
Tacrolimus—Hypersensitivity—Triamcinolone—ulcerative colitis	3.3e-05	0.00016	CcSEcCtD
Tacrolimus—MTOR—Immune System—IRF8—ulcerative colitis	3.3e-05	0.000399	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CCR6—ulcerative colitis	3.3e-05	0.000399	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.3e-05	0.00016	CcSEcCtD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	3.27e-05	0.000396	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ADRB2—ulcerative colitis	3.26e-05	0.000395	CbGpPWpGaD
Tacrolimus—Diarrhoea—Hydrocortisone—ulcerative colitis	3.26e-05	0.000158	CcSEcCtD
Tacrolimus—ALB—Platelet degranulation—TGFB1—ulcerative colitis	3.25e-05	0.000393	CbGpPWpGaD
Tacrolimus—Urticaria—Dexamethasone—ulcerative colitis	3.23e-05	0.000157	CcSEcCtD
Tacrolimus—Urticaria—Betamethasone—ulcerative colitis	3.23e-05	0.000157	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Prednisone—ulcerative colitis	3.23e-05	0.000157	CcSEcCtD
Tacrolimus—Dizziness—Prednisolone—ulcerative colitis	3.23e-05	0.000156	CcSEcCtD
Tacrolimus—Asthenia—Triamcinolone—ulcerative colitis	3.22e-05	0.000156	CcSEcCtD
Tacrolimus—Body temperature increased—Betamethasone—ulcerative colitis	3.22e-05	0.000156	CcSEcCtD
Tacrolimus—Body temperature increased—Dexamethasone—ulcerative colitis	3.22e-05	0.000156	CcSEcCtD
Tacrolimus—Abdominal pain—Betamethasone—ulcerative colitis	3.22e-05	0.000156	CcSEcCtD
Tacrolimus—Abdominal pain—Dexamethasone—ulcerative colitis	3.22e-05	0.000156	CcSEcCtD
Tacrolimus—MTOR—Disease—SLC11A1—ulcerative colitis	3.21e-05	0.000389	CbGpPWpGaD
Tacrolimus—Asthenia—Methylprednisolone—ulcerative colitis	3.21e-05	0.000156	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—ADCY5—ulcerative colitis	3.21e-05	0.000388	CbGpPWpGaD
Tacrolimus—Insomnia—Prednisone—ulcerative colitis	3.21e-05	0.000155	CcSEcCtD
Tacrolimus—Paraesthesia—Prednisone—ulcerative colitis	3.18e-05	0.000154	CcSEcCtD
Tacrolimus—Pruritus—Triamcinolone—ulcerative colitis	3.17e-05	0.000154	CcSEcCtD
Tacrolimus—Pruritus—Methylprednisolone—ulcerative colitis	3.17e-05	0.000154	CcSEcCtD
Tacrolimus—MTOR—Signaling by SCF-KIT—IL6—ulcerative colitis	3.17e-05	0.000383	CbGpPWpGaD
Tacrolimus—Dizziness—Hydrocortisone—ulcerative colitis	3.15e-05	0.000153	CcSEcCtD
Tacrolimus—MTOR—Immune System—FCGR2A—ulcerative colitis	3.15e-05	0.000381	CbGpPWpGaD
Tacrolimus—Dyspepsia—Prednisone—ulcerative colitis	3.12e-05	0.000151	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—TP53—ulcerative colitis	3.12e-05	0.000378	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	3.09e-05	0.000375	CbGpPWpGaD
Tacrolimus—Decreased appetite—Prednisone—ulcerative colitis	3.08e-05	0.000149	CcSEcCtD
Tacrolimus—Rash—Prednisolone—ulcerative colitis	3.08e-05	0.000149	CcSEcCtD
Tacrolimus—Dermatitis—Prednisolone—ulcerative colitis	3.07e-05	0.000149	CcSEcCtD
Tacrolimus—FKBP1A—Disease—ADCY5—ulcerative colitis	3.07e-05	0.000371	CbGpPWpGaD
Tacrolimus—Diarrhoea—Methylprednisolone—ulcerative colitis	3.06e-05	0.000149	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—GHRL—ulcerative colitis	3.06e-05	0.00037	CbGpPWpGaD
Tacrolimus—Fatigue—Prednisone—ulcerative colitis	3.06e-05	0.000148	CcSEcCtD
Tacrolimus—Headache—Prednisolone—ulcerative colitis	3.06e-05	0.000148	CcSEcCtD
Tacrolimus—MTOR—Cellular responses to stress—NFKB1—ulcerative colitis	3.05e-05	0.00037	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CDH1—ulcerative colitis	3.05e-05	0.000369	CbGpPWpGaD
Tacrolimus—Constipation—Prednisone—ulcerative colitis	3.03e-05	0.000147	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—IL6—ulcerative colitis	3.03e-05	0.000367	CbGpPWpGaD
Tacrolimus—Vomiting—Hydrocortisone—ulcerative colitis	3.03e-05	0.000147	CcSEcCtD
Tacrolimus—CYP3A5—Metabolism—CHP1—ulcerative colitis	3.02e-05	0.000366	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PTPN2—ulcerative colitis	3.02e-05	0.000365	CbGpPWpGaD
Tacrolimus—Rash—Hydrocortisone—ulcerative colitis	3e-05	0.000146	CcSEcCtD
Tacrolimus—Dermatitis—Hydrocortisone—ulcerative colitis	3e-05	0.000146	CcSEcCtD
Tacrolimus—Headache—Hydrocortisone—ulcerative colitis	2.98e-05	0.000145	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB4—IL6—ulcerative colitis	2.98e-05	0.000361	CbGpPWpGaD
Tacrolimus—Dizziness—Triamcinolone—ulcerative colitis	2.97e-05	0.000144	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—CALM3—ulcerative colitis	2.96e-05	0.000358	CbGpPWpGaD
Tacrolimus—Dizziness—Methylprednisolone—ulcerative colitis	2.96e-05	0.000144	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—JAK2—ulcerative colitis	2.92e-05	0.000354	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Prednisone—ulcerative colitis	2.92e-05	0.000142	CcSEcCtD
Tacrolimus—Asthenia—Betamethasone—ulcerative colitis	2.92e-05	0.000142	CcSEcCtD
Tacrolimus—Asthenia—Dexamethasone—ulcerative colitis	2.92e-05	0.000142	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—RIPK2—ulcerative colitis	2.92e-05	0.000353	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCR1—ulcerative colitis	2.9e-05	0.000351	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Prednisone—ulcerative colitis	2.9e-05	0.000141	CcSEcCtD
Tacrolimus—Nausea—Prednisolone—ulcerative colitis	2.9e-05	0.000141	CcSEcCtD
Tacrolimus—MTOR—Disease—MAML2—ulcerative colitis	2.89e-05	0.00035	CbGpPWpGaD
Tacrolimus—Pruritus—Betamethasone—ulcerative colitis	2.88e-05	0.00014	CcSEcCtD
Tacrolimus—Pruritus—Dexamethasone—ulcerative colitis	2.88e-05	0.00014	CcSEcCtD
Tacrolimus—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	2.87e-05	0.000348	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—NFKB1—ulcerative colitis	2.86e-05	0.000347	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL6—ulcerative colitis	2.85e-05	0.000346	CbGpPWpGaD
Tacrolimus—Vomiting—Triamcinolone—ulcerative colitis	2.85e-05	0.000138	CcSEcCtD
Tacrolimus—MTOR—Downstream signal transduction—IL6—ulcerative colitis	2.85e-05	0.000345	CbGpPWpGaD
Tacrolimus—Vomiting—Methylprednisolone—ulcerative colitis	2.85e-05	0.000138	CcSEcCtD
Tacrolimus—MTOR—Signaling by FGFR—IL6—ulcerative colitis	2.83e-05	0.000343	CbGpPWpGaD
Tacrolimus—Nausea—Hydrocortisone—ulcerative colitis	2.83e-05	0.000137	CcSEcCtD
Tacrolimus—Rash—Triamcinolone—ulcerative colitis	2.83e-05	0.000137	CcSEcCtD
Tacrolimus—Dermatitis—Triamcinolone—ulcerative colitis	2.83e-05	0.000137	CcSEcCtD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.82e-05	0.000342	CbGpPWpGaD
Tacrolimus—Rash—Methylprednisolone—ulcerative colitis	2.82e-05	0.000137	CcSEcCtD
Tacrolimus—Dermatitis—Methylprednisolone—ulcerative colitis	2.82e-05	0.000137	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB2—IL6—ulcerative colitis	2.82e-05	0.000341	CbGpPWpGaD
Tacrolimus—Urticaria—Prednisone—ulcerative colitis	2.82e-05	0.000137	CcSEcCtD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	2.81e-05	0.00034	CbGpPWpGaD
Tacrolimus—Headache—Triamcinolone—ulcerative colitis	2.81e-05	0.000136	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—CRP—ulcerative colitis	2.81e-05	0.00034	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—IL6—ulcerative colitis	2.81e-05	0.00034	CbGpPWpGaD
Tacrolimus—Headache—Methylprednisolone—ulcerative colitis	2.8e-05	0.000136	CcSEcCtD
Tacrolimus—Abdominal pain—Prednisone—ulcerative colitis	2.8e-05	0.000136	CcSEcCtD
Tacrolimus—Body temperature increased—Prednisone—ulcerative colitis	2.8e-05	0.000136	CcSEcCtD
Tacrolimus—Diarrhoea—Dexamethasone—ulcerative colitis	2.78e-05	0.000135	CcSEcCtD
Tacrolimus—Diarrhoea—Betamethasone—ulcerative colitis	2.78e-05	0.000135	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—ADCY5—ulcerative colitis	2.77e-05	0.000335	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—STAT3—ulcerative colitis	2.74e-05	0.000332	CbGpPWpGaD
Tacrolimus—Dizziness—Betamethasone—ulcerative colitis	2.69e-05	0.000131	CcSEcCtD
Tacrolimus—Dizziness—Dexamethasone—ulcerative colitis	2.69e-05	0.000131	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—TLR4—ulcerative colitis	2.69e-05	0.000326	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.68e-05	0.000325	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—JAK2—ulcerative colitis	2.67e-05	0.000323	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CXCL8—ulcerative colitis	2.67e-05	0.000323	CbGpPWpGaD
Tacrolimus—Nausea—Triamcinolone—ulcerative colitis	2.66e-05	0.000129	CcSEcCtD
Tacrolimus—Nausea—Methylprednisolone—ulcerative colitis	2.66e-05	0.000129	CcSEcCtD
Tacrolimus—MTOR—DAP12 interactions—IL6—ulcerative colitis	2.64e-05	0.00032	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—IL6—ulcerative colitis	2.64e-05	0.00032	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	2.64e-05	0.00032	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IFNG—ulcerative colitis	2.62e-05	0.000317	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—IL6—ulcerative colitis	2.62e-05	0.000317	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Prednisone—ulcerative colitis	2.61e-05	0.000127	CcSEcCtD
Tacrolimus—CYP3A5—Metabolism—DLD—ulcerative colitis	2.61e-05	0.000316	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CHP1—ulcerative colitis	2.6e-05	0.000315	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—IL6—ulcerative colitis	2.59e-05	0.000314	CbGpPWpGaD
Tacrolimus—Vomiting—Betamethasone—ulcerative colitis	2.59e-05	0.000126	CcSEcCtD
Tacrolimus—Vomiting—Dexamethasone—ulcerative colitis	2.59e-05	0.000126	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—RELA—ulcerative colitis	2.59e-05	0.000313	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-DRB1—ulcerative colitis	2.58e-05	0.000313	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—IL6—ulcerative colitis	2.58e-05	0.000312	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CALM3—ulcerative colitis	2.58e-05	0.000312	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—STAT3—ulcerative colitis	2.57e-05	0.000312	CbGpPWpGaD
Tacrolimus—Rash—Dexamethasone—ulcerative colitis	2.57e-05	0.000124	CcSEcCtD
Tacrolimus—Rash—Betamethasone—ulcerative colitis	2.57e-05	0.000124	CcSEcCtD
Tacrolimus—Dermatitis—Betamethasone—ulcerative colitis	2.56e-05	0.000124	CcSEcCtD
Tacrolimus—Dermatitis—Dexamethasone—ulcerative colitis	2.56e-05	0.000124	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—IL2—ulcerative colitis	2.55e-05	0.000309	CbGpPWpGaD
Tacrolimus—Headache—Betamethasone—ulcerative colitis	2.55e-05	0.000124	CcSEcCtD
Tacrolimus—Headache—Dexamethasone—ulcerative colitis	2.55e-05	0.000124	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—CCL20—ulcerative colitis	2.55e-05	0.000308	CbGpPWpGaD
Tacrolimus—Asthenia—Prednisone—ulcerative colitis	2.54e-05	0.000123	CcSEcCtD
Tacrolimus—MTOR—Immune System—RIPK2—ulcerative colitis	2.54e-05	0.000307	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD4—ulcerative colitis	2.53e-05	0.000307	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ADRB2—ulcerative colitis	2.53e-05	0.000306	CbGpPWpGaD
Tacrolimus—Pruritus—Prednisone—ulcerative colitis	2.51e-05	0.000122	CcSEcCtD
Tacrolimus—MTOR—Immune System—CTLA4—ulcerative colitis	2.5e-05	0.000303	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—ICAM1—ulcerative colitis	2.48e-05	0.0003	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.47e-05	0.000299	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—JAK2—ulcerative colitis	2.47e-05	0.000299	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.44e-05	0.000295	CbGpPWpGaD
Tacrolimus—Diarrhoea—Prednisone—ulcerative colitis	2.43e-05	0.000118	CcSEcCtD
Tacrolimus—Nausea—Dexamethasone—ulcerative colitis	2.42e-05	0.000117	CcSEcCtD
Tacrolimus—Nausea—Betamethasone—ulcerative colitis	2.42e-05	0.000117	CcSEcCtD
Tacrolimus—ALB—Hemostasis—CALM3—ulcerative colitis	2.41e-05	0.000292	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GNA12—ulcerative colitis	2.39e-05	0.00029	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD79A—ulcerative colitis	2.39e-05	0.000289	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CALM3—ulcerative colitis	2.38e-05	0.000288	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—IL6—ulcerative colitis	2.35e-05	0.000285	CbGpPWpGaD
Tacrolimus—Dizziness—Prednisone—ulcerative colitis	2.34e-05	0.000114	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—IL1B—ulcerative colitis	2.34e-05	0.000283	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CD4—ulcerative colitis	2.34e-05	0.000283	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	2.34e-05	0.000283	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL2—ulcerative colitis	2.33e-05	0.000282	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PTGS2—ulcerative colitis	2.32e-05	0.000281	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—NOD2—ulcerative colitis	2.3e-05	0.000278	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD14—ulcerative colitis	2.29e-05	0.000277	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CHP1—ulcerative colitis	2.28e-05	0.000276	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCR2—ulcerative colitis	2.27e-05	0.000275	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	2.27e-05	0.000275	CbGpPWpGaD
Tacrolimus—Vomiting—Prednisone—ulcerative colitis	2.25e-05	0.000109	CcSEcCtD
Tacrolimus—ALB—Metabolism—DLD—ulcerative colitis	2.25e-05	0.000272	CbGpPWpGaD
Tacrolimus—Rash—Prednisone—ulcerative colitis	2.23e-05	0.000108	CcSEcCtD
Tacrolimus—Dermatitis—Prednisone—ulcerative colitis	2.23e-05	0.000108	CcSEcCtD
Tacrolimus—Headache—Prednisone—ulcerative colitis	2.22e-05	0.000108	CcSEcCtD
Tacrolimus—MTOR—Immune System—VCAM1—ulcerative colitis	2.21e-05	0.000267	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DQA1—ulcerative colitis	2.2e-05	0.000267	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CDH1—ulcerative colitis	2.19e-05	0.000265	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—NFKB1—ulcerative colitis	2.18e-05	0.000264	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ADCY5—ulcerative colitis	2.15e-05	0.00026	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCR6—ulcerative colitis	2.13e-05	0.000258	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	2.12e-05	0.000256	CbGpPWpGaD
Tacrolimus—Nausea—Prednisone—ulcerative colitis	2.11e-05	0.000102	CcSEcCtD
Tacrolimus—MTOR—Cellular responses to stress—TP53—ulcerative colitis	2.09e-05	0.000254	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAML2—ulcerative colitis	2.02e-05	0.000245	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—JAK2—ulcerative colitis	2e-05	0.000242	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DLD—ulcerative colitis	1.97e-05	0.000238	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.96e-05	0.000238	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—STAT3—ulcerative colitis	1.96e-05	0.000237	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—RELA—ulcerative colitis	1.94e-05	0.000235	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—ulcerative colitis	1.92e-05	0.000232	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—JAK2—ulcerative colitis	1.91e-05	0.000232	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD4—ulcerative colitis	1.9e-05	0.00023	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTGER4—ulcerative colitis	1.88e-05	0.000227	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ADCY5—ulcerative colitis	1.87e-05	0.000226	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—RELA—ulcerative colitis	1.86e-05	0.000225	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	1.85e-05	0.000224	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD4—ulcerative colitis	1.82e-05	0.00022	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CD4—ulcerative colitis	1.81e-05	0.000219	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—STAT3—ulcerative colitis	1.81e-05	0.000219	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTGS2—ulcerative colitis	1.8e-05	0.000218	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—ulcerative colitis	1.8e-05	0.000218	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS1—ulcerative colitis	1.75e-05	0.000211	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—JAK2—ulcerative colitis	1.73e-05	0.000209	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ADCY5—ulcerative colitis	1.73e-05	0.000209	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GHRL—ulcerative colitis	1.72e-05	0.000208	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.7e-05	0.000206	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFB1—ulcerative colitis	1.68e-05	0.000203	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RELA—ulcerative colitis	1.67e-05	0.000203	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CALM3—ulcerative colitis	1.67e-05	0.000202	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RIPK2—ulcerative colitis	1.64e-05	0.000199	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CRP—ulcerative colitis	1.63e-05	0.000198	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—NFKB1—ulcerative colitis	1.63e-05	0.000198	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.62e-05	0.000197	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CXCL8—ulcerative colitis	1.58e-05	0.000191	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CALM3—ulcerative colitis	1.57e-05	0.00019	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—NFKB1—ulcerative colitis	1.57e-05	0.00019	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TLR4—ulcerative colitis	1.57e-05	0.00019	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DRB1—ulcerative colitis	1.57e-05	0.00019	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—MMP1—ulcerative colitis	1.55e-05	0.000188	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.52e-05	0.000184	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL2—ulcerative colitis	1.51e-05	0.000182	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ICAM1—ulcerative colitis	1.5e-05	0.000182	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—ulcerative colitis	1.5e-05	0.000181	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.44e-05	0.000174	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MMP9—ulcerative colitis	1.43e-05	0.000173	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADRB2—ulcerative colitis	1.42e-05	0.000172	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.42e-05	0.000172	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NFKB1—ulcerative colitis	1.41e-05	0.000171	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.41e-05	0.00017	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—STAT3—ulcerative colitis	1.4e-05	0.00017	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—ulcerative colitis	1.37e-05	0.000166	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—JAK2—ulcerative colitis	1.34e-05	0.000162	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CDH1—ulcerative colitis	1.33e-05	0.000161	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.33e-05	0.000161	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.32e-05	0.00016	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFB1—ulcerative colitis	1.3e-05	0.000158	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RELA—ulcerative colitis	1.3e-05	0.000157	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—STAT3—ulcerative colitis	1.27e-05	0.000153	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—ulcerative colitis	1.26e-05	0.000153	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS1—ulcerative colitis	1.26e-05	0.000153	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ABCB1—ulcerative colitis	1.22e-05	0.000148	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL8—ulcerative colitis	1.22e-05	0.000148	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DLD—ulcerative colitis	1.21e-05	0.000147	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADCY5—ulcerative colitis	1.21e-05	0.000146	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.19e-05	0.000144	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFB1—ulcerative colitis	1.18e-05	0.000142	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2—ulcerative colitis	1.17e-05	0.000141	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.17e-05	0.000141	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—JAK2—ulcerative colitis	1.16e-05	0.000141	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNG—ulcerative colitis	1.14e-05	0.000138	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ADCY5—ulcerative colitis	1.14e-05	0.000138	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CALM3—ulcerative colitis	1.14e-05	0.000138	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—RELA—ulcerative colitis	1.13e-05	0.000137	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP9—ulcerative colitis	1.11e-05	0.000134	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD4—ulcerative colitis	1.1e-05	0.000134	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NFKB1—ulcerative colitis	1.09e-05	0.000132	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—JAK2—ulcerative colitis	1.09e-05	0.000132	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS1—ulcerative colitis	1.09e-05	0.000132	CbGpPWpGaD
Tacrolimus—MTOR—Disease—JAK2—ulcerative colitis	1.08e-05	0.00013	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—ulcerative colitis	1.03e-05	0.000124	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—ulcerative colitis	1.02e-05	0.000123	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD4—ulcerative colitis	1.02e-05	0.000123	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2—ulcerative colitis	1.02e-05	0.000123	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTGS2—ulcerative colitis	1.01e-05	0.000123	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—STAT3—ulcerative colitis	9.83e-06	0.000119	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—ulcerative colitis	9.8e-06	0.000119	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CALM3—ulcerative colitis	9.78e-06	0.000118	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—ulcerative colitis	9.67e-06	0.000117	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS1—ulcerative colitis	9.52e-06	0.000115	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2—ulcerative colitis	9.52e-06	0.000115	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—NFKB1—ulcerative colitis	9.51e-06	0.000115	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.35e-06	0.000113	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—ulcerative colitis	9.11e-06	0.00011	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.91e-06	0.000108	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—ulcerative colitis	8.85e-06	0.000107	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ABCB1—ulcerative colitis	8.84e-06	0.000107	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CALM3—ulcerative colitis	8.57e-06	0.000104	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—STAT3—ulcerative colitis	8.55e-06	0.000104	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PPARG—ulcerative colitis	8.5e-06	0.000103	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ADCY5—ulcerative colitis	8.24e-06	9.98e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—STAT3—ulcerative colitis	7.89e-06	9.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—ulcerative colitis	7.65e-06	9.26e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ABCB1—ulcerative colitis	7.61e-06	9.21e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—JAK2—ulcerative colitis	7.53e-06	9.12e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—ulcerative colitis	7.5e-06	9.08e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—ulcerative colitis	7.43e-06	8.99e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—ulcerative colitis	7.32e-06	8.86e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RELA—ulcerative colitis	7.29e-06	8.83e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ADCY5—ulcerative colitis	7.1e-06	8.59e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL8—ulcerative colitis	6.87e-06	8.32e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—ulcerative colitis	6.87e-06	8.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—ulcerative colitis	6.69e-06	8.1e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2—ulcerative colitis	6.57e-06	7.95e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ADCY5—ulcerative colitis	6.22e-06	7.53e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—ulcerative colitis	6.22e-06	7.53e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NFKB1—ulcerative colitis	6.15e-06	7.45e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARG—ulcerative colitis	6.15e-06	7.44e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—ulcerative colitis	6.11e-06	7.4e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—ulcerative colitis	5.97e-06	7.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS1—ulcerative colitis	5.87e-06	7.1e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—STAT3—ulcerative colitis	5.53e-06	6.69e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—ulcerative colitis	5.53e-06	6.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—ulcerative colitis	5.51e-06	6.68e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARG—ulcerative colitis	5.29e-06	6.41e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CALM3—ulcerative colitis	5.28e-06	6.4e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—ulcerative colitis	5.12e-06	6.2e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—ulcerative colitis	4.84e-06	5.86e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARG—ulcerative colitis	4.64e-06	5.62e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—ulcerative colitis	4.22e-06	5.11e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—ulcerative colitis	4.17e-06	5.05e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—ulcerative colitis	4.16e-06	5.04e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.11e-06	4.97e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—ulcerative colitis	3.86e-06	4.68e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ADCY5—ulcerative colitis	3.83e-06	4.64e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.65e-06	4.42e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.86e-06	3.46e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—ulcerative colitis	2.57e-06	3.11e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.25e-06	2.72e-05	CbGpPWpGaD
